Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes
Yi Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Dong Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 104
Related Papers
Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases
|Nature Communications|2019|74
Berberine Improves Glucose and Lipid Metabolism in HepG2 Cells Through AMPKα1 Activation
|Frontiers in Pharmacology|2020|47